Senate Passes Bills On Drug Patent Listings
The U.S. Senate has unanimously passed two bills that would tidy up U.S. Food and Drug Administration regulations on patents for drugs and biologics in an effort to boost competition in...To view the full article, register now.
Already a subscriber? Click here to view full article